Alka Seltzer Plus Cold Day And Night Effervescent Tablet
NDC Package 71992-154-20
Package Information
Alka Seltzer Plus Cold Day And Night Effervescent (aspirin, dextromethorphan hydrobromide, phenylephrine bitartrate) tablets is ● adults and children 12 years and over: take 2 tablets fully dissolved in 4 oz of water at bedtime (may be taken every 4 to 6 hours). This formulation utilizes a tablet delivery system. Marketed by Sincronia Logistica, S.a. De C.v., this product is identified by NDC 71992-154 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1536498 - aspirin 325 MG / dextromethorphan HBr 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
- RxCUI: 1536498 - aspirin 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
- RxCUI: 1536498 - ASA 325 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 71992 - Sincronia Logistica, S.a. De C.v.
- 71992-154 - Alka Seltzer Plus Cold Day And Night Effervescent
- 71992-154-20 - 20 TABLET in 1 CARTON
- 71992-154 - Alka Seltzer Plus Cold Day And Night Effervescent
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71992-154-20 identifies a specific commercial package of 20 tablet in 1 carton of Alka Seltzer Plus Cold Day And Night Effervescent, a human over the counter drug labeled by Sincronia Logistica, S.a. De C.v.. This tablet is formulated for oral use and contains aspirin; dextromethorphan hydrobromide; phenylephrine bitartrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sincronia Logistica, S.a. De C.v. on July 02, 2018. The current certification is valid through December 31, 2026.
How is this Sincronia Logistica, S.a. De C.v. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71992015420. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.